XML 23 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Earnings - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Profit or loss [abstract]      
Revenue (Note 21) $ 1,531,469 $ 1,213,028 $ 1,158,519
Cost of sales 1,191,495 924,244 911,644
Gross profit 339,974 288,784 246,875
Selling, general and administrative expenses 177,139 157,486 136,674
Research expenses 11,882 11,196 12,527
Operating expenses 189,021 168,682 149,201
Operating profit before manufacturing facility closures, restructuring and other related charges 150,953 120,102 97,674
Manufacturing facility closures, restructuring and other related charges (Note 4) 0 4,328 5,136
Operating profit 150,953 115,774 92,538
Finance costs (income) (Note 3)      
Interest 27,676 29,436 31,690
Other expense (income), net 29,208 (6,238) 3,314
Finance costs (income) 56,884 23,198 35,004
Earnings before income tax expense 94,069 92,576 57,534
Income tax expense (benefit) (Note 5)      
Current 22,113 25,595 17,195
Deferred 1,951 (6,474) (885)
Income tax expense (benefit) 24,064 19,121 16,310
Net earnings 70,005 73,455 41,224
Net earnings attributable to:      
Company shareholders 67,813 72,670 41,216
Non-controlling interests 2,192 785 8
Net earnings $ 70,005 $ 73,455 $ 41,224
Earnings per share attributable to Company shareholders (Note 6)      
Basic (in dollars per share) $ 1.15 $ 1.23 $ 0.70
Diluted (in dollars per share) $ 1.12 $ 1.22 $ 0.70